A detailed history of Rice Hall James & Associates, LLC transactions in Biote Corp. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 227,024 shares of BTMD stock, worth $592,532. This represents 0.04% of its overall portfolio holdings.

Number of Shares
227,024
Previous 121,655 86.61%
Holding current value
$592,532
Previous $489,000 39.26%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 16, 2025

BUY
$2.82 - $4.55 $297,140 - $479,428
105,369 Added 86.61%
227,024 $681,000
Q2 2025

Aug 11, 2025

BUY
$3.25 - $4.28 $395,378 - $520,683
121,655 New
121,655 $489,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $19.8M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.